125 related articles for article (PubMed ID: 28413959)
1. Chemopreventive Properties of Tolfenamic Acid: A Mechanistic Review.
Feldman D; Leahy E; Lee SH
Curr Med Chem; 2018; 25(14):1598-1608. PubMed ID: 28413959
[TBL] [Abstract][Full Text] [Related]
2. Tolfenamic acid induces apoptosis and growth inhibition in anaplastic thyroid cancer: Involvement of nonsteroidal anti-inflammatory drug-activated gene-1 expression and intracellular reactive oxygen species generation.
Chang JW; Kang SU; Choi JW; Shin YS; Baek SJ; Lee SH; Kim CH
Free Radic Biol Med; 2014 Feb; 67():115-30. PubMed ID: 24216474
[TBL] [Abstract][Full Text] [Related]
3. Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells.
Sankpal UT; Goodison S; Jones-Pauley M; Hurtado M; Zhang F; Basha R
Oncotarget; 2017 Feb; 8(9):14593-14603. PubMed ID: 28099934
[TBL] [Abstract][Full Text] [Related]
4. ESE-1/EGR-1 pathway plays a role in tolfenamic acid-induced apoptosis in colorectal cancer cells.
Lee SH; Bahn JH; Choi CK; Whitlock NC; English AE; Safe S; Baek SJ
Mol Cancer Ther; 2008 Dec; 7(12):3739-50. PubMed ID: 19074849
[TBL] [Abstract][Full Text] [Related]
5. Tolfenamic acid downregulates β-catenin in colon cancer.
Ha T; Lou Z; Baek SJ; Lee SH
Int Immunopharmacol; 2016 Jun; 35():287-293. PubMed ID: 27089389
[TBL] [Abstract][Full Text] [Related]
6. Tolfenamic acid enhances pancreatic cancer cell and tumor response to radiation therapy by inhibiting survivin protein expression.
Konduri S; Colon J; Baker CH; Safe S; Abbruzzese JL; Abudayyeh A; Basha MR; Abdelrahim M
Mol Cancer Ther; 2009 Mar; 8(3):533-42. PubMed ID: 19258429
[TBL] [Abstract][Full Text] [Related]
7. Anti-tumor activity of non-steroidal anti-inflammatory drugs: cyclooxygenase-independent targets.
Liggett JL; Zhang X; Eling TE; Baek SJ
Cancer Lett; 2014 May; 346(2):217-24. PubMed ID: 24486220
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic applications of NSAIDS in cancer: special emphasis on tolfenamic acid.
Basha R; Baker CH; Sankpal UT; Ahmad S; Safe S; Abbruzzese JL; Abdelrahim M
Front Biosci (Schol Ed); 2011 Jan; 3(2):797-805. PubMed ID: 21196413
[TBL] [Abstract][Full Text] [Related]
9. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species mediate tolfenamic acid-induced apoptosis in human colorectal cancer cells.
Jeong JB; Choi J; Baek SJ; Lee SH
Arch Biochem Biophys; 2013 Sep; 537(2):168-75. PubMed ID: 23896517
[TBL] [Abstract][Full Text] [Related]
11. Copper-tolfenamic acid: evaluation of stability and anti-cancer activity.
Hurtado M; Sankpal UT; Chhabra J; Brown DT; Maram R; Patel R; Gurung RK; Simecka J; Holder AA; Basha R
Invest New Drugs; 2019 Feb; 37(1):27-34. PubMed ID: 29761244
[TBL] [Abstract][Full Text] [Related]
12. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
Pathi S; Li X; Safe S
Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
[TBL] [Abstract][Full Text] [Related]
13. Tolfenamic acid induces apoptosis and growth inhibition in head and neck cancer: involvement of NAG-1 expression.
Kang SU; Shin YS; Hwang HS; Baek SJ; Lee SH; Kim CH
PLoS One; 2012; 7(4):e34988. PubMed ID: 22536345
[TBL] [Abstract][Full Text] [Related]
14. The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression.
Liu X; Abdelrahim M; Abudayyeh A; Lei P; Safe S
Mol Cancer Ther; 2009 May; 8(5):1207-17. PubMed ID: 19435870
[TBL] [Abstract][Full Text] [Related]
15. Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma.
Eslin D; Sankpal UT; Lee C; Sutphin RM; Maliakal P; Currier E; Sholler G; Khan M; Basha R
Mol Carcinog; 2013 May; 52(5):377-86. PubMed ID: 22213339
[TBL] [Abstract][Full Text] [Related]
16. Influence of tolfenamic acid on airway contractility in guinea pigs.
Rydberg IG; Andersson RG
Pharmacol Toxicol; 1994; 75 Suppl 2():33-6. PubMed ID: 7816777
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory, antiproliferative, and radical-scavenging activities of tolfenamic acid and its metal complexes.
Kovala-Demertzi D; Hadjipavlou-Litina D; Primikiri A; Staninska M; Kotoglou C; Demertzis MA
Chem Biodivers; 2009 Jun; 6(6):948-60. PubMed ID: 19551737
[TBL] [Abstract][Full Text] [Related]
18. Anticancer Properties of Capsaicin Against Human Cancer.
Clark R; Lee SH
Anticancer Res; 2016 Mar; 36(3):837-43. PubMed ID: 26976969
[TBL] [Abstract][Full Text] [Related]
19. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
[TBL] [Abstract][Full Text] [Related]
20. A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-κB activation.
Jeong JB; Yang X; Clark R; Choi J; Baek SJ; Lee SH
Carcinogenesis; 2013 Oct; 34(10):2350-60. PubMed ID: 23784084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
